Bibliografía

1. Global Antimicrobial Resistance. Alerts and Implications. The Alliance for the Prudent Use of Antibiotics. CID 2005:41 (Suppl 4) pag S221-223.
2. Goodman y Gilman. Las Bases Farmacológicas de la terapéutica. Oncena Edición. 2006. Principios Generales de la antibioticoterapia.cap. 42.(1095-1110).
3. Physician Antibiotic Prescribing Practices and Knowledge in Seven Countries in Latin America and the Caribbean. A PAHO/APUA Report. January 2002.vercoming Microbial Resistance. Infectious Disease Report 2000. World Health Organization-http://www.who.int/infectious-disease-report/2000/htm.
4. Resistencia Bacteriana en las Américas. Revista Panamericana de Infectologia. May 1999:Vol 3.
5. Estrella Álvarez Varela. Generalización de la utilización de los mapas microbianos en la salud publica nacional.CNIC. 2006.
6. Alexandre Spatuzza. La resistencia a los antibióticos: ¿Estamos acabando con los remedios? Revista de la OPS. Volumen 7, Número 1, 2002
7. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group (Campos J, Spain). Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365:579-87.
8. Oteo J, Navarro C, Cercenado E, Delgado-Iribarren A, Wilhelmi I, Orden B, García C, Miguelañez S, Pérez-Vázquez M, García S, Aracil B, Bautista V, Campos J. High-level of cefotaxime and ceftazidime resistance in Escherichia coli: Spread of clonal and unrelated isolates between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 2006; 44:2359-66.
9. World Wide Web Resources on Antimicrobial Resistance Matthew E. Falagas1,2 and Efthymia A. Karveli 1Alfa Institute of Biomedical Sciences, Athens, Greece; and Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts.
10. Talbot GH, Bradley J, Edwards JE, et al. Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America. Clin Infect Dis 2006; 42:657–68. Johnson DM, Stilwell MG, Fritsche TR, et al. Emergence of multidrugresistant
11. Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999–2003). Diagn Microbiol Infect Dis. 2006